Insider sale
LANTERN PHARMA INC.
$346.0K
105.18K shares
What this filing means
BIOS FUND II QP, LP plans to sell 105.18K shares of LANTERN PHARMA INC. valued at approximately $346.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/27/2025ACC: 0001104659-25-053170
105.18K
Shares to sell
$346.0K
Approx. market value
723.61K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Conversion of Shares in IPO
Conversion
6/15/2020
723.61KTotal acquired723.61K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/15/2020 | Conversion of Shares in IPO Conversion | 723.61K | — |
| Total | 723.61K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
105.18K
Market value
$346.0K
5/27/2025
Total
Units
105.18K
Value
$346.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/27/2025 | 105.18K | $346.0K | NASDAQ | Planned |
| Total | 105.18K | $346.0K | ||